Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells	Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, epithelial neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, primitive neuroectodermal tumor	Active, not recruiting	Phase 1	2026-03-23		NCT02573896

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Nationwide Children's Hospital	97
New Approaches to Neuroblastoma Therapy Consortium	7
United Therapeutics	18

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus	Atlanta	United States	2
C.S Mott Children's Hospital	Ann Arbor	United States	7
Children's Hospital Los Angeles	Los Angeles	United States	6
Children's Hospital of Philadelphia	Philadelphia	United States	6
Childrens Hospital Boston, Dana-Farber Cancer Institute.	Boston	United States	4
Cincinnati Children's Hospital Medical Center	Cincinnati	United States	21
Cook Children's Healthcare System	Fort Worth	United States	3
Nationwide Children's Hospital	Columbus	United States	309
Seattle Children's Hospital	Seattle	United States	281
UCSF Helen Diller Family Comprehensive Cancer Center	San Francisco	United States	9
University of Chicago Comer Children's Hospital	Chicago	United States	4